Liangliang He

951 total citations · 1 hit paper
47 papers, 665 citations indexed

About

Liangliang He is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Liangliang He has authored 47 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Pharmacology and 10 papers in Complementary and alternative medicine. Recurrent topics in Liangliang He's work include Metabolomics and Mass Spectrometry Studies (10 papers), Traditional Chinese Medicine Analysis (10 papers) and Pharmacological Effects of Natural Compounds (10 papers). Liangliang He is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (10 papers), Traditional Chinese Medicine Analysis (10 papers) and Pharmacological Effects of Natural Compounds (10 papers). Liangliang He collaborates with scholars based in China, Thailand and United States. Liangliang He's co-authors include Zhenhua Tan, Zhihong Yao, Jiaxu Chen, Yi Dai, Xin‐Sheng Yao, Zifei Qin, Wenzhi Hao, Qingyu Ma, Naijun Yuan and Junqing Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Journal of Agricultural and Food Chemistry.

In The Last Decade

Liangliang He

44 papers receiving 660 citations

Hit Papers

Gut dysbiosis induces the development of depression-like ... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangliang He China 15 289 133 126 75 69 47 665
Jue Wang China 17 664 2.3× 75 0.6× 76 0.6× 40 0.5× 74 1.1× 65 1.3k
Sung‐Soo Kim South Korea 18 408 1.4× 63 0.5× 86 0.7× 25 0.3× 101 1.5× 44 1.0k
Yao Gao China 16 548 1.9× 80 0.6× 86 0.7× 121 1.6× 35 0.5× 68 972
Baoying Wang China 18 330 1.1× 57 0.4× 46 0.4× 52 0.7× 150 2.2× 65 875
Chang-Ho Lee South Korea 17 307 1.1× 109 0.8× 100 0.8× 71 0.9× 170 2.5× 84 1.0k
Fareeha Anwar Pakistan 20 259 0.9× 140 1.1× 201 1.6× 40 0.5× 226 3.3× 73 1.2k
Sujuan Wang China 14 318 1.1× 88 0.7× 118 0.9× 7 0.1× 118 1.7× 51 1.0k
Xuan Yuan China 19 416 1.4× 289 2.2× 101 0.8× 7 0.1× 146 2.1× 34 969
Zhenzhen Kou China 15 596 2.1× 359 2.7× 154 1.2× 12 0.2× 147 2.1× 36 1.0k
Ing‐Jun Chen Taiwan 26 802 2.8× 110 0.8× 121 1.0× 15 0.2× 103 1.5× 115 1.8k

Countries citing papers authored by Liangliang He

Since Specialization
Citations

This map shows the geographic impact of Liangliang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangliang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangliang He more than expected).

Fields of papers citing papers by Liangliang He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangliang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangliang He. The network helps show where Liangliang He may publish in the future.

Co-authorship network of co-authors of Liangliang He

This figure shows the co-authorship network connecting the top 25 collaborators of Liangliang He. A scholar is included among the top collaborators of Liangliang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangliang He. Liangliang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qi, Haodong Zhu, Hong Zhou, et al.. (2025). Integrating mass defect filtering and targeted molecular networking for foodomics research: A case study of Magnolia officinalis cortex. Food Research International. 210. 116441–116441.
2.
Chen, Chanjuan, Pei Lin, Zhen Wu, et al.. (2025). Farnesoid X receptor regulates CYP1A1 and CYP1B1 and estradiol metabolism in mouse and human cell lines. Chemico-Biological Interactions. 412. 111471–111471.
3.
Chen, Jiali, Zhenyu Zou, Jing Du, et al.. (2024). Quantitative ternary network-oriented discovery of Q-markers from traditional Chinese medicine prescriptions: Bu-Zhong-Yi-Qi-Tang as a case study. Phytomedicine. 133. 155918–155918. 6 indexed citations
4.
Lin, Yanke, Liangliang He, Yuting Cai, et al.. (2024). The role of circadian clock in regulating cell functions: implications for diseases. SHILAP Revista de lepidopterología. 5(3). e504–e504. 15 indexed citations
5.
Hao, Wenzhi, Qingyu Ma, Lu Wang, et al.. (2024). Gut dysbiosis induces the development of depression-like behavior through abnormal synapse pruning in microglia-mediated by complement C3. Microbiome. 12(1). 56 indexed citations breakdown →
6.
Yu, Wei, et al.. (2023). A Systematic Review on Password Guessing Tasks. Entropy. 25(9). 1303–1303. 6 indexed citations
7.
Wang, Qiqi, et al.. (2023). Activity labelled molecular networking fuels the antioxidation active molecules profile of Ginger. Food Chemistry. 424. 136343–136343. 9 indexed citations
8.
Zhu, Haodong, Liangliang He, Jiali Chen, et al.. (2023). A compounds annotation strategy using targeted molecular networking for offline two-dimensional liquid chromatography-mass spectrometry analysis: Yupingfeng as a case study. Journal of Chromatography A. 1702. 464045–464045. 11 indexed citations
9.
He, Liangliang, Qiang Xiao, Xintong Chen, et al.. (2023). A multi-module structure labelled molecular network orients the chemical profiles of traditional Chinese medicine prescriptions: Xiaoyao San, as an example. Journal of Chromatography A. 1715. 464613–464613.
10.
Xia, Xichun, Yingying Zhang, Leqing Zhu, et al.. (2023). Liquiritin apioside alleviates colonic inflammation and accompanying depression-like symptoms in colitis by gut metabolites and the balance of Th17/Treg. Phytomedicine. 120. 155039–155039. 31 indexed citations
11.
Ma, Xiaohui, Qi Wang, Chun‐Yu Liu, et al.. (2023). Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease. Phytomedicine. 114. 154749–154749. 14 indexed citations
12.
14.
Zou, Denglang, Qiqi Wang, Tao Chen, et al.. (2022). Bufadienolides originated from toad source and their anti-inflammatory activity. Frontiers in Pharmacology. 13. 1044027–1044027. 19 indexed citations
15.
Tang, Kairui, Dongdong Liu, Liangliang He, et al.. (2022). Xiaoyao San, a Chinese herbal formula, ameliorates depression-like behavior in mice through the AdipoR1/AMPK/ACC pathway in hypothalamus. Journal of Integrative Medicine. 20(5). 442–452. 5 indexed citations
16.
He, Liangliang, Chanjuan Chen, Yang Li, et al.. (2022). Inhibition of estrogen sulfation by Xian-Ling-Gu-Bao capsule. The Journal of Steroid Biochemistry and Molecular Biology. 225. 106182–106182. 8 indexed citations
17.
Tang, Kairui, Wenzhi Hao, Yueyue Chen, et al.. (2022). Analysis of the therapeutic effect of Dimu Ningshen (TCM formula) on attention deficit hyperactivity disorder based on gut microbiota and serum metabolomics. BMC Complementary Medicine and Therapies. 22(1). 24–24. 8 indexed citations
18.
Tan, Zhenhua, et al.. (2019). SDP: An Improved Baseline Estimation Model Based On Standard Deviation Proportion. 5. 25–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026